Asset 2Asset 2Asset 2Asset 2
  • Capabilities
    • Trial Design and Management
    • Data Management
    • Regulatory and Quality
    • Consulting and Program Management
    • Biospecimens and Logistics
  • Expertise
    • Trial Types
    • Health Innovation Solutions
    • Clinical Applications
  • About Us
    • Company
    • Management Team
  • News & Events
  • Contact
✕
            No results See all results
            • Filter by
            • Categories
            • Tags
            • Authors
            • Show all
            • All
            • Events
            • GBC Blog
            • In Vitro Diagnostics - IVD News
            • Press Releases
            • All
            • All
            • neil.mucci@globalbioclinical.com
            June 30, 2021
            Published by admin on June 30, 2021
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Announces Prospective Clinical Data from Unyvero LRT BAL and Acuitas AMR Gene Panel for Isolates Data Presented at World Microbe Forum

            GAITHERSBURG, Md., June 30, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, […]
            Do you like it?0
            Read more
            March 8, 2021
            Published by admin on March 8, 2021
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patients with COVID-19 Pneumonia

            GAITHERSBURG, Md., and Holzgerlingen, Germany, March 08, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics […]
            Do you like it?0
            Read more
            March 2, 2021
            Published by admin on March 2, 2021
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System

            GAITHERSBURG, Md., March 01, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to […]
            Do you like it?0
            Read more
            January 25, 2021
            Published by admin on January 25, 2021
            Categories
            • In Vitro Diagnostics - IVD News

            Epigenomics AG Plans to Challenge National Coverage Determination (NCD) Decision and Unveils Its Next Generation Liquid Biopsy Test for Colorectal Cancer Screening

            Berlin (Germany) and San Diego, CA (USA), January 21, 2020 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the “Company”) announces that the management disagrees […]
            Do you like it?0
            Read more
            December 17, 2020
            Published by admin on December 17, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Unyvero LRT BAL Panel Provides Accurate Detection in Bronchoalveolar Lavage (BAL) Fluid, Allowing Enhanced Diagnosis of Lower Respiratory Tract Infections

            GAITHERSBURG, Md. and HOLZGERLINGEN, Germany, Dec. 17, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics […]
            Do you like it?0
            Read more
            November 2, 2020
            Published by admin on November 2, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            World’s Fastest PCR-Based SARS-CoV-2 Test Now Available on Randox-Bosch Vivalytic POC Analyzer

            29 Oct 2020. A rapid new coronavirus test, which provides results for COVID-19 in just 39 minutes, is now available on the Vivalytic, a point of […]
            Do you like it?0
            Read more
            October 28, 2020
            Published by admin on October 28, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators

            GAITHERSBURG, Md. and HOLZGERLINGEN, Germany, Oct. 28, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics […]
            Do you like it?0
            Read more
            October 13, 2020
            Published by admin on October 13, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Issues Formal Response to FDA’s Requests for Additional Information and Expects Near Term FDA Clearance Decision for Acuitas AMR Gene Panel

            GAITHERSBURG, Md., Oct. 13, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to […]
            Do you like it?0
            Read more
            September 30, 2020
            Published by admin on September 30, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators

            GAITHERSBURG, Md., and HOLZGERLINGEN, Germany, Sept. 30, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat […]
            Do you like it?0
            Read more
            Prev page
            1234567891011121314
            Next page

            Global BioClinical
            600 1st Avenue, Suite 330 PMB 80042
            Seattle, WA 98104-2246 USA

            Tel: +1 888 659 1221
            Fax: +1 206 299 9895
            Email: info@globalbioclinical.com

            Capabilities

            Trial Design and Management

            Data Management

            Regulatory and Quality

            Consulting and Program Management

            Biospecimens and Logistics

            Expertise

            Trial Types

            Health Innovation Solutions

            Clinical Applications

            About Us

            Company

            Management Team

            News & Events

            Contact

            © 2025 Global BioClinical. All rights reserved. | Privacy Policy

                      No results See all results
                      ✕